CLINICAL_TRIALS
trial_result
· 2013-05-22
Clinical Trial Update: Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD [Phase 2]
Summary
Phase 2 trial investigating lanthanum carbonate effects on FGF-23 in subjects with stage 3 chronic kidney disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-05-22